Derynck Mika K: insider trades.
Derynck Mika K reported 5 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($9.6M), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 1
- Companies
- 1
- Name as filed
- Derynck Mika K
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | Director | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-04 | Enliven Therapeutics, Inc. | S | 158,795 | $60.21 | 0 | Form 4 |
| 2026-08-04 | Enliven Therapeutics, Inc. | M | 20,491 | $22.47 | 158,795 | Form 4 |
| 2026-08-04 | Enliven Therapeutics, Inc. | M | 23,364 | $14.85 | 138,304 | Form 4 |
| 2026-08-04 | Enliven Therapeutics, Inc. | M | 27,567 | $25.28 | 114,940 | Form 4 |
| 2026-08-04 | Enliven Therapeutics, Inc. | M | 87,373 | $2.48 | 87,373 | Form 4 |
Questions
What stock did Derynck Mika K buy or sell?
Derynck Mika K reported 5 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($9.6M), across 1 company.
Is Derynck Mika K the same person as other filers with this name?
This page covers SEC CIK 1865125 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/derynck-mika-k-1865125.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.